D. Western Therapeutics Institute (4576) Key Financial Indicators

104
+3+2.97%

20min DelayNot Open Jan 15 15:30 JST

5.64BMarket Cap-2.83P/E (Static)

4576 Free Cash Flow (FCF)

Interested in knowing about D. Western Therapeutics Institute's free cash flow? The latest report shows it as 122.90M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: JPY

Quarterly

4576 Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of D. Western Therapeutics Institute shows that the company's current ratio is 12.65, indicating healthy liquidity.

Currency: JPY

Quarterly

4576 Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of D. Western Therapeutics Institute, the quick ratio is 10.65, indicating that the company can meet its short-term debt obligations.

Currency: JPY

Quarterly

4576 Return on Equity (ROE)

Want to learn more about the financial health of D. Western Therapeutics Institute? The latest ROE figure is -22.02%, indicating that the company has stable profitability.

Currency: JPY

Quarterly

4576 Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of D. Western Therapeutics Institute, the total asset return on investment (ROA) is -9.56%.

Currency: JPY

Quarterly

4576 Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check D. Western Therapeutics Institute's latest financial report to see how their gross margin is doing - currently at 92.08%.

Currency: JPY

Quarterly

4576 Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of D. Western Therapeutics Institute, the net profit margin is -168.36%, which is a good sign for its profitability.

Currency: JPY

Quarterly

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"